Key result
During the late 2018 UK epidemic, EV-D68 was detected in 58% of confirmed enterovirus cases, with subclade B3 predominating in children and younger adults and subclade D1 in older adults (p=0.0009).
Why the study?
Enterovirus D68 (EV-D68) has been identified in biennial epidemics coinciding with diagnoses of non-polio acute flaccid paralysis/myelitis.
Observational (n=194)
No
Answers are grounded in this paper and cite their sources.
The 2018 UK EV-D68 epidemic was driven by two genetically diverse subclades (B3 and D1) that affected different age groups but caused similar respiratory clinical presentations.
Enterovirus D68 (EV-D68) has been recently identified in biennial epidemics coinciding with diagnoses of non-polio acute flaccid paralysis/myelitis (AFP/AFM). We investigated the prevalence, genetic relatedness and associated clinical features of EV-D68 in 194 known EV positive samples from late 2018, UK. EV-D68 was detected in 83 (58%) of the 143 EV positive samples. Sequencing and phylogenetic analysis revealed an extensive genetic diversity, split between subclades B3 (n=50) and D1 (n=33), suggesting epidemiologically unrelated infections. B3 predominated in children and younger adults, and D1 in older adults and the elderly (p=0.0009). Clinical presentation indicated causation or exacerbation of respiratory distress in 91.4% of EV-D68-positive individuals, principally: cough (75.3%), shortness of breath (56.8%), coryza (48.1%), wheeze (46.9%), supplemental oxygen required (46.9%) and fever (38.9%). Clinical features were not distinguished by subclade. Two cases of AFM were observed, one with EV-D68 detectable in the cerebrospinal fluid, otherwise neurological symptoms were rarely reported (n=4).
No takes yet. Share an insight, caveat, or question.
Howson‐Wells et al. (2021) conducted an observational in Enterovirus D68 infection (n=194). Enterovirus D68 subclades B3 and D1 was evaluated on Age distribution by EV-D68 subclade (p=0.0009). During the late 2018 UK epidemic, EV-D68 was detected in 58% of confirmed enterovirus cases, with subclade B3 predominating in children and younger adults and subclade D1 in older adults (p=0.0009).
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: